3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Thyroid Nodule
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Spinal Fractures
1
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Phyllodes Tumor
1
Pancreatic Neoplasms
1
Osteoporosis
1
Nevus
1
Neoplasms
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Liver Cirrhosis
1
Hypertension, Portal
1
Glioma
1
Fibrosis
1
Dysplastic Nevus Syndrome
1
Disease
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Radiotherapy
3
Nivolumab
3
pembrolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Paclitaxel
2
ONC206
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
Biopsy
2
regorafenib
1
pegfilgrastim
1
mirdametinib
1
lutetium Lu 177 dotatate
1
fludarabine
1
etoposide phosphate
1
entrectinib
1
entinostat
1
elacestrant
1
decitabine and cedazuridine drug combination
1
cabozantinib
1
amino-acid, glucose, and electrolyte solution
1
alectinib
1
aflibercept
1
abemaciclib
1
Topotecan
1
Tissue Banks
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Central Nervous System Neoplasms
×
Diagnostic Imaging
×
Clear all
NCT06381531
2025-04-11
TRACE
Tata Memorial Centre
Recruiting
10,000 enrolled